Aspirin showdown: finding the best dose to protect moms and babies
NCT ID NCT07041385
Summary
This study aims to find out if a 150mg daily dose of aspirin is better than the standard 75mg dose at preventing preeclampsia, a dangerous high blood pressure condition in pregnancy. It will involve 340 pregnant women in Pakistan who are at high risk for developing this condition. The goal is to determine which dose provides stronger protection for both mother and baby.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA (PE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shalamar Hospital
Lahore, Punjab Province, 54000, Pakistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.